CVE-2026-52866: CWE-862 in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT)
CVE-2026-52866 affects the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT) version 0x0110_v1.1.0. An attacker within Bluetooth Low Energy (BLE) communication range can monopolize the device's single BLE connection slot, preventing legitimate users or applications from connecting. This denial of service condition impacts device availability but does not compromise confidentiality or integrity.
AI Analysis
Technical Summary
This vulnerability (CVE-2026-52866) in the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT) allows an attacker in BLE range to occupy the device's only BLE connection slot, effectively blocking legitimate connections. The issue is classified as CWE-862 (Missing Authorization) because the device does not properly restrict or manage BLE connection requests, enabling an unauthorized actor to cause a denial of service. The CVSS v3.1 base score is 6.5 (medium severity), with attack vector as adjacent network (BLE), low attack complexity, no privileges required, no user interaction, unchanged scope, no confidentiality or integrity impact, but high availability impact. No patch or official remediation is currently available.
Potential Impact
The vulnerability causes a denial of service by preventing legitimate users or applications from establishing a BLE connection to the device. This impacts device availability but does not affect confidentiality or integrity of data. There are no known exploits in the wild at this time.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until a fix is available, users should limit physical access to the device and BLE communication range to trusted individuals to reduce the risk of exploitation.
CVE-2026-52866: CWE-862 in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT)
Description
CVE-2026-52866 affects the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT) version 0x0110_v1.1.0. An attacker within Bluetooth Low Energy (BLE) communication range can monopolize the device's single BLE connection slot, preventing legitimate users or applications from connecting. This denial of service condition impacts device availability but does not compromise confidentiality or integrity.
CVSS v3.1
Score 6.5medium
Weaknesses
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
This vulnerability (CVE-2026-52866) in the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT) allows an attacker in BLE range to occupy the device's only BLE connection slot, effectively blocking legitimate connections. The issue is classified as CWE-862 (Missing Authorization) because the device does not properly restrict or manage BLE connection requests, enabling an unauthorized actor to cause a denial of service. The CVSS v3.1 base score is 6.5 (medium severity), with attack vector as adjacent network (BLE), low attack complexity, no privileges required, no user interaction, unchanged scope, no confidentiality or integrity impact, but high availability impact. No patch or official remediation is currently available.
Potential Impact
The vulnerability causes a denial of service by preventing legitimate users or applications from establishing a BLE connection to the device. This impacts device availability but does not affect confidentiality or integrity of data. There are no known exploits in the wild at this time.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until a fix is available, users should limit physical access to the device and BLE communication range to trusted individuals to reduce the risk of exploitation.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- icscert
- Date Reserved
- 2026-06-10T21:21:12.261Z
- Cvss Version
- 3.1
- State
- PUBLISHED
- Remediation Level
- null
Threat ID: 6a357436f198dc38c1bc0f43
Added to database: 6/19/2026, 4:54:14 PM
Last enriched: 6/19/2026, 4:55:35 PM
Last updated: 6/19/2026, 6:46:00 PM
Views: 4
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.